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Virus protein translationTo study the contribution of the protease-sensitive loop of the VSV M protein in virus assembly we recovered
recombinant VSV (rVSV) with mutations in this region and examined virus replication. Mutations in the
highly conserved LXD motif (aa 123–125) resulted in reduced virion budding, reduced virus titers and
enhanced M protein exchange with M-ribonucleocapsid complexes (M-RNPs), suggesting that the mutant M
proteins were less tightly associated with RNP skeletons. In addition, viral protein synthesis began to decrease
at 4 h post-infection (hpi) and was reduced by ~80% at 8 hpi for the mutant rVSV-D125A. The reduced protein
synthesis was not due to decreased VSV replication or transcription; however, translation of a reporter gene
with an EMCV IRES was not reduced, suggesting that cap-dependent, but not cap-independent translation
initiation was affected in rVSV-D125A infected cells. These results indicate that the LXD motif is involved in
both virus assembly and VSV protein translation., Department of Microbiology
niversity Boulevard, Galveston,
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Vesicular stomatitis virus (VSV) is a simple, enveloped, non-
segmented negative-strand RNA virus that has served as a good
model to study virus replication and assembly. There are two major
serotypes of VSV found in the United States, VSV-Indiana (VSV-Ind)
and VSV-New Jersey (VSV-NJ), both of which are part of a larger group
of related vesiculoviruses that belong to the family Rhabdoviridae. The
genome of VSV encodes the nucleocapsid (N) protein, the phospho-
protein (P), the matrix (M) protein, the glycoprotein (G), and the
large (L) polymerase protein. The viral genomic RNA is encapsidated
by the N protein and is associated with the RNA-dependent RNA
polymerase (RdRp), which consists of a complex of the L and P pro-
teins. Together, the encapsidated genome and associated RdRp make
up the ribonucleoprotein particle (RNP). During virus assembly at the
plasma membrane, RNPs localize to membrane microdomains con-
taining G protein to form budding sites (Brown and Lyles, 2003a,
2003b). The M protein, which is found in both the cytoplasm and
associated with the inner leaﬂet of the plasma membrane, is recruited
into budding sites (Swinteck and Lyles, 2008) where it condenses the
RNP into a tightly packed helix called the skeleton (Newcomb and
Brown, 1981; Newcomb et al., 1982). Recently, cryo-electron micro-
scopy (cryo-EM) of VSV-Ind virions revealed that the skeleton is a left-handed helix with M on the outside of the RNP anchoring it to the
viral membrane (Ge et al., 2010). Surrounding the skeleton is the viral
envelope derived from the host cell plasma membrane with G protein
trimers protruding from the surface. The M protein of VSV plays a key
role in virus assembly by condensing the RNP and it also contributes
to the release of virions by budding from the cell surface (Chong and
Rose, 1994; Harty et al., 2001; Jayakar et al., 2000). The M protein is
also responsible for inducing the cytopathic effects (CPE) character-
istic of a VSV infection, which include disruption of cytoskeletal
organization, inhibition of host mRNA expression, inhibition of host
translation, impeding nucleocytoplasmic transport, and induction of
apoptosis (Ahmed and Lyles, 1998; Ahmed et al., 2003; Connor and
Lyles, 2005; Faria et al., 2005; Petersen et al., 2000).
Biochemical studies suggest that an exposed protease-sensitive
loop (amino acids 120-PAVLADQGQP-129) in Mmay be important for
assembly of virions. Cleavage of this region in theM protein fromVSV-
Ind with the protease thermolysin resulted in an M protein that no
longer self-associates (Gaudier et al., 2001, 2002). M self-association
has been implicated in condensation of RNPs (Gaudin et al., 1995;
Newcomb et al., 1982), which is critical for the formation of the bullet-
shaped particles characteristic of rhabdovirus virions (Lyles et al.,
1996; Mebatsion et al., 1999). The recent cryo-EM analysis of VSV
virions led to a model of virion assembly where the loop region was
important for M-M interactions between consecutive helical turns of
the RNP (Ge et al., 2010). This was supported by the determination of
the crystal structure of the M protein from VSV-NJ, which included
amino acids 122–127 of the loop, and which showed that the
N-terminal region of an adjacentMmonomer interactedwith the loop
region in self-assembled M oligomers (Graham et al., 2008).
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M in virus assembly, Connor and Lyles (Connor et al., 2006) mutated
the hydrophobic core of the loop from AVLA to KDQQ. Interestingly,
the effect on virus assembly was minor, but the mutations resulted in
reduced viral protein synthesis. Here, we report on the effect of
additional mutations within the loop region on viral protein synthesis
and VSV-Ind assembly. Characterization of the mutants revealed no
effect on the cellular distribution or the in vitro budding activity of
the M mutants compared to wild-type M protein (Mwt); however,
attempts to recover recombinant virus encoding some of the mutants
were unsuccessful. For those that were recovered, the viruses grew to
lower titers and produced less total virus, indicating that the muta-
tions in the loop may have affected virus assembly. Metabolic labeling
studies with rVSV-infected cells revealed that one of the mutants
(D125A) had reduced levels of viral protein synthesis beginning at
4 hpi, similar to that reported previously by Connor et al. (2006). The
reduced protein synthesis for our mutant was not due to reduced
genome replication or mRNA transcription. These results suggest
that the protease-sensitive loop in VSV-Ind M is important for VSV
assembly and that it also positively regulates translation by an
unknown mechanism. Sequence analysis of this region identiﬁed a
conserved LXD motif (residues 123–125 for VSV-Ind M) that is found
in the matrix proteins of other vesiculoviruses, suggesting that the
LXD sequence may represent an interaction motif important for
reversible assembly–disassembly reactions, such as is needed during
virus assembly and uncoating.
Results
Recovery and characterization of rVSVs with M loop mutations
Previous studies by Gaudier et al. (2001, 2002) identiﬁed a
protease-sensitive loop in the M protein of VSV-Ind that, when
digested with thermolysin, prevented the self-association of M andFig. 1. Identiﬁcation of a conserved LXD motif and characterization of M protein loop muta
was generated using coordinates from the VSV-Ind M crystal structure (MMDB ID: 50117; PD
from 6 different vesiculoviruses were aligned using Clustal W and the location of the
leucine/isoleucine (green highlight) are shown. (B) Schematic of mutations made in the pro
in red and underlined are either mutated to the amino acids shown, or are added (2X Loop)
121 and 129 deleted. All constructs have a tetracysteine Lumio tag at the C-terminus. (C) Tra
anti-M monoclonal antibody conjugated to Alexa-546 and examined by LSCM. The image
showing intracellular protein expression (odd numbered lanes) and M protein budded in
transfected cells.allowed M protein to be crystallized. Using coordinates from the M
crystal structures of VSV-Ind and VSV-NJ (Graham et al., 2008), this
region is clearly seen as a loop (Fig. 1A) extending from the main
framework of the M structure. Alignment of the putative loop regions
from several different vesiculovirus M proteins revealed that the
leucine and aspartate residues within this region are conserved
(Fig. 1A). Amino acids that were not present in the crystal structure
of M-Ind are shown in lower case as are the residues released after
thermolysin cleavage. Based on the vesiculovirus M alignments
(Fig. 1A), we constructed a series of mutations (Fig. 1B) to determine
whether the loop itself (Δ Loop), the size of the loop (2X Loop), or
speciﬁc amino acids within the loop were involved in the assembly
and budding of VSV. All of the constructs included a C-terminal
tetracysteine (Lumio) tag, which we have shown does not affect M
protein localization, budding activity, or uncoating when assembled
into virus particles (Mire et al., 2009, 2010).
To examine the effect of the mutations on the cellular distribution
and function of M, we transiently expressed the proteins in BHK cells
and compared them to wild-type M protein (Mwt) by immunoﬂu-
orescence microscopy (IF) and by an in vitro budding assay. There
were no discernable differences in the intracellular distributions of
the M loop mutants after staining with a monoclonal anti-M antibody
(23H12) conjugated to Alexa-546 (Fig. 1C). The loop mutants (only
D125A is shown) also had wild-type budding activity (Fig. 1D).
To determine if the M loop mutants could support virus assembly
we replaced the Mwt gene in the viral genome with those encoding
the loop mutants (Fig. 1B). In contrast to the results of the in vitro
budding assay where all of the mutants showed wild-type budding
activity, only viruses with single amino acid substitutions (D125A,
L123A, and L123S) were recovered. Multiple attempts (n=6) to
recover the other viruses were unsuccessful. One-step growth curves
revealed that the L123A, L123S, and D125Amutant viruses grewmore
slowly, produced small plaques, and generated ﬁnal titers that were
approximately one-log less than rVSV-wt (Fig. 2A). Because all threents. (A) Location of the protease-sensitive loop in VSV M protein is shown. The image
B ID: 1LG7 (Gaudier et al., 2002)) and viewed in 3D Molecule Viewer. The loop regions
conserved aspartate residue (red font with yellow highlight) and semiconserved
tease-sensitive loop region of M and their location within rVSV genomes. The residues
. The Δ Loop mutant has all amino acids between the two proline residues at positions
nsient expression of Mwt and the D125A loop mutant in BHK-21 cells stained using an
s shown are 1 μm optical sections through the middle of the cell. (D) Budding assay
to the supernatant in mock transfected (lane 2), Mwt (lane 4), and D125A (lane 6)
Fig. 2. Characterization of rVSV-M loop mutants. (A) One-step growth curves of rVSV-M mutants and rVSV-wt in BHK-21 cells. Average titers from the experiment performed in
triplicate are shown. (B) Coomassie-blue stained SDS-polyacyrlamide gel of 107 PFU of rVSV-D125A (lane 1) and rVSV-wt (lane 2). (C) Transmission electronmicrographs of puriﬁed
rVSV-D125A (D125A) and rVSV-wt (Wt) virions at 130,000× magniﬁcation. Bar represents 20 nm. (D) Phase-contrast images of BHK-21 cells infected with rVSV-wt (Wt) or rVSV-
D125A (D125A) at 12 and 24 hpi.
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D125A mutant since the aspartate residue of the LXD motif was the
most highly conserved between the vesiculoviruses M proteins
(Fig. 1A).
To determine if the reduced infectivity was due to differences in
the amount of G or M protein incorporated into virions we assessed
the relative infectivity of the viruses released in the one-step
growth curve. Proteins from 107 plaque forming units (PFU) of the
rVSV-D125A and rVSV-wt virions were separated by SDS-PAGE and
stained using Coomassie-blue (Fig. 2B). The protein compositions
from equivalent amounts of infectious virus were similar indicating
that the reduced infectivity for rVSV-D125A was due to fewer virions
being released from infected cells and not because less G or M pro-
tein was present, or because the virions were inherently less infec-
tious. We then compared the morphology of puriﬁed virions by
negative-stain transmission electron microscopy (TEM). The mor-
phologies of the rVSV-D125A loop mutant and rVSV-wt (Wt) weresimilar with bullet-shaped virions and helically condensed RNPs
(Fig. 2C), suggesting that the reduced titers were not due to gross
changes in virion structure.
In addition to the reduced titers, another notable difference
between the D125A mutant and rVSV-wt was that infection with
rVSV-D125A did not cause cell rounding (Fig. 2D). A similar pheno-
type was observed by others (Connor et al., 2006) for a different type
of loop mutant in which the hydrophobic amino acids (121-AVLA-
124) were changed to charged and polar residues (121-DKQQ-124;
rVSV-ΦM). Infection of MDCK cells with rVSV-ΦM did not result in
typical VSV-induced cell rounding. However, cell rounding with
rVSV-ΦMwas observed in BHK infected cells (Connor et al., 2006). In
contrast, BHK cells infected with rVSV-D125A did not show typical
VSV CPE (Fig. 2D). The cells retained their ﬁbroblast-like appearance,
but the cells appeared to be in a quiescent state and did not grow
(compare the number of mock-infected versus D125A-infected cells
at 24 h post-infection (hpi) in Fig. 2D).
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To determine if the reduced titers for rVSV-D125A were due to
defects in the release of virions from infected cells when compared to
rVSV-wt infected cells, we performed virus budding assays. BHK cells
were infected and pulse-labeled with 35S-Met at 3 hpi for 1 h.
Released virus was puriﬁed from the cell supernatants and cell
lysates were prepared immediately after the pulse and the labeled
proteins were analyzed by SDS-PAGE. To determine the efﬁciency of
virus budding we compared the amount of labeled N protein in virus
particles released in the supernatant to the amount of N protein in
cell lysates. For rVSV-D125A infected cells only 1.3% of labeled N
protein was released from cells at this time point, while approxi-Fig. 3. Analysis of infectious virus production andM-skeleton exchange for rVSV-D125A. (A) A
numbered lanes) after mock infection (lanes 1 and 2), or after infection with rVSV-wt (lanes
for 1 h at 3 hpi. Labeled virus released in the culture supernatant was harvested by cent
ﬂuorography and the ratio of virus (N protein) released in the supernatant (VP, viral pell
quantiﬁcation by phosphorimaging. (B) Virus budding assays for rVSV-wt, rVSV-D125A, and
curves from cells infected with rVSV-wt (MOI=1), rVSV-D125A (MOI=10), or co-infected
Skeletons from rVSV-wt (top panel) or rVSV-D125A (bottom panel) were incubated with so
mixtures were centrifuged over a sucrose cushion to separate skeletons and associated M p
theM-skeleton exchange assay results showing the inability of rVSV-wt skeletons to exchange
the input M proteins. (For interpretation of the references to colour in this ﬁgure legend, thmately 12% of labeled N protein was released from rVSV-wt infected
cells (Fig. 3A).
To determine if the reduced level of virus budding could be
rescued by Mwt we co-infected cells with rVSV-wt and rVSV-D125A.
To eliminate possible variability in the rate of virus internalization
between the two viruses and to ensure that the cells were infected
simultaneously, we synchronized infection by allowing virus to
endocytose in the presence of ammonium chloride and then washed
out the drug to initiate infection. In other studies we have found that
the number of cells that become co-infected versus singly infected
wasmuch higher when fusion is synchronized by ammonium chloride
washout as compared to normal (non-synchronized) infection con-
ditions (Watanabe, Mire, and Whitt, unpublished data). For thesemount of viral protein synthesis in cells (odd numbered lanes) and released virus (even
3 and 4) or rVSV-D125A (lanes 5 and 6). Cells were pulse-labeled with 35S-methionine
rifugation and cell lysates were prepared. Samples were analyzed by SDS-PAGE and
et) to the amount of N protein in cell lysates (CE, cell extract) was determined after
rVSV-wt+D125A were performed and quantiﬁed as described in (A). (C) Virus growth
with rVSV-wt (MOI=1) and rVSV-D125A (MOI=10). (D) M-skeleton exchange assay.
luble, in vitro translated, 35S-methionine labeled Mwt or D125A. After incubation, the
roteins (P; pellet) from unincorporated, soluble M (S; supernatant). (E) Depiction of
with input M (green dots) versus the ability of the rVSV-D125A skeletons to incorporate
e reader is referred to the web version of this article.)
Fig. 4. Reduced viral protein synthesis at late times post-infection in rVSV-D125A
infected cells. (A) BHK-21 cells were mock infected (lane 1) or infected with rVSV-wt
(lanes 3, 5, 7, and 9), or rVSV-D125A (lanes 2, 4, 6, and 8) and then pulse-labeled with
35S-methionine at the times indicated. Cell lysates were prepared immediately after the
pulse and analyzed directly by SDS-PAGE. The slower migration of the D125A protein is
due to the C-terminal Lumio tag. (B) Quantitation of the amount of N protein labeled
during the 10 min pulse at 8 hpi in wt and D125A infected cells. Percent of wt N is
shown for experiments done in triplicate (error bars; standard deviation). (C) HeLa
cells were infected with rVSV-wt (lanes 1, 3, 5, and 7) or rVSV-D125A (lanes 2, 4, 6, and
8) at an MOI of 10 and pulse-labeled with 35S-methionine at increasing times post-
infection and cell lysates examined by SDS-PAGE and ﬂuorography. (D) 35S-methionine
pulsed BHK-21 cell lysates from cells transiently expressing D125A (lane 1) or Mwt
(lane 2) using the vaccinia-T7 expression system. (E) 35S-methionine labeled D125A
(lane 1) and Mwt (lane 2) protein synthesized in rabbit reticulolysates from an in vitro
transcription-translation reaction.
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of 1 and rVSV-D125A using a multiplicity of 10 to ensure that any
effects seen were not due to more extensive or rapid replication of
rVSV-wt. Analysis of virus growth indicated that virus replication and
ﬁnal virus titers produced by the singly infected cells were not
affected by synchronization with NH4Cl (compare Figs. 2A and 3C),
but that co-infection resulted in a partial rescue of the amount of virus
produced (Fig. 3C). Quantiﬁcation of N protein expression at 4 hpi in
Fig. 3B showed that the amount of N protein released (viral pellet
(VP)/cell extract (CE) from rVSV-wt infected cells was approximately
16% of total N, while the D125A infected cells released only 0.9%.
Co-infection increased the amount of virus released to 8% of total
cellular N protein, which suggests that the D125A mutant is not
dominant-negative for virion assembly or release.
rVSV-D125A M-RNP skeletons exchange more efﬁciently with input
M proteins
To determine if the decrease in virus release seen with the D125A
mutant could be due to reduced interaction of the mutant M protein
with RNPs and consequently result in inefﬁcient RNP condensation
and budding, we performed a skeleton-M protein exchange assay,
which was based on an assay described previously (Flood and Lyles,
1999) with modiﬁcations. The modiﬁed assay measures the ability of
labeled M protein to bind with unlabeled skeletons released from the
viral envelope versus the previously described assay (Flood and Lyles,
1999) in which most of the M protein was removed from puriﬁed
skeletons before examining reassociation or exchange of M with RNPs
at different NaCl concentrations. Our modiﬁcation tests the ability of
the skeleton to exchange M proteins as opposed to binding of M to
RNPs. Using this assay to examine the efﬁciency of D125A RNP con-
densation of skeletons, we took 10, 50, or 100 μg of puriﬁed rVSV-wt or
rVSV-D125A and detergent solubilized in the presence of 35S-Met
labeled wt or D125A M proteins that had been synthesized in an in
vitro translation system. Skeletons with newly bound labeled M
proteins were then separated from soluble M by ultracentrifugation
and the pellets and supernatants were analyzed by SDS-PAGE and
ﬂuorography. We observed that the rVSV-wt skeletons did not incor-
porate any input 35S-Met labeled M protein even with the highest
amount of virus used where more skeletons would be available to
exchange with input M (Fig. 3D, Wt skeleton). In contrast, the D125A
skeletons exchanged with each of the input labeled M proteins
regardless of the amount of skeletons in the assay (Fig. 3D, D125A
skeleton). These data suggested that the D125A M protein was less
tightly associated with skeletons isolated from rVSV-D125A virions.
Alternatively, the D125A-skeletons may be less condensed and
therefore could allow more binding of exogenous M protein as
depicted in Fig. 3E.
rVSV loop mutants have reduced protein synthesis at late times
post-infection
Previously it was shown that rVSV-ΦMhad a defect in viral protein
synthesis (Connor et al., 2006). To determine if our rVSV-M loop
mutants had a similar translation defective phenotype we infected
BHK cells at an MOI of 10 and pulse-labeled the cells with 35S-Met for
10 min at 6 hpi since this was the time point which Connor et. al.
began to see viral protein translation defects. Whole cell lysates were
prepared and analyzed by SDS-PAGE and radioﬂuorography, and the
relative amounts of N and P proteins synthesized during the 10 min
pulse were quantiﬁed using phosphorimager analysis. Quantiﬁcation
of viral protein synthesis compared to rVSV-wt indicated that
rVSV-D125A had the most pronounced reduction in viral protein
translation at 6 hpi when compared to the otherM loopmutants (data
not shown).To examine the difference in viral protein synthesis between rVSV-
wt and rVSV-D125A infected cells in more detail, BHK cells were
pulse-labeled with 35S-Met for 10 min at 2, 4, 6, and 8 hpi and
analyzed as described above. The synthesis of viral and host cellular
proteins was similar for the two viruses at 2 and 4 hpi, and the
characteristic inhibition of cellular protein synthesis was seen for
both viruses at 4 hpi. However, by 6 and 8 hpi there was a dramatic
reduction in viral protein synthesis for the rVSV-D125A mutant.
Quantiﬁcation of viral protein synthesis at 8 hpi from rVSV-D125A
infected cells showed an 82% reduction compared to rVSV-wt levels
(Fig. 4A, lane 8, and B). Based on the lack of other proteins that were
detected in the cell lysate at 8 hpi, it appears that there was very little
viral or cellular protein synthesis occurring in the rVSV-D125A
Fig. 5. Relative levels of VSV mRNA synthesis in rVSV-infected cells. (A) Quantitative
RT-PCR was used to quantify the relative amount of phosphoprotein (P) mRNA to viral
genomic RNA (mRNA/gEq) in rVSV-wt (Wt) and rVSV-D125A (D125A) infected cells at
1, 5, and 7 hpi. (B) qRT-PCR shows that the amount of genomic RNA for each virus was
similar in these experiments (n=3; error bars, standard deviation).
21C.E. Mire, M.A. Whitt / Virology 416 (2011) 16–25infected cells at this time point. This reduction in VSV protein
synthesis at later times post-infection was also seen in HeLa cells
(Fig. 4C) and the timing of the reduction was similar. The lack of
protein labeling was not due to an inhibition of 35S-Met uptake by the
cells as the intracellular pools of soluble 35S-Met were similar for wt-
and D125A-infected cells (data not shown).
Transient or in vitro expression of the D125A mutant does not affect
protein synthesis
To determine if reduced VSV protein synthesis was induced by
the mutant M protein alone we transiently expressed the D125A or
wild-typeM (Mwt) proteins in cells using the vaccinia-T7 system, and
examined the relative amount of M protein made after a 10 min pulse
labeling with 35S-Met at 18 h post-transfection (Fig. 4D). We also
analyzed protein expression using an in vitro transcription and
translation system and compared the amount of protein synthesized
by the D125A mutant and Mwt by SDS-PAGE, ﬂuorography, and
phosphorimaging (Fig. 4E). There was no difference in the amount of
M protein synthesized in the absence of a VSV infection (Fig. 4D and E)Fig. 6. Co-infection with rVSV-wt and rVSV-D125A partially rescues protein translation defec
wt (MOI 1; lane 1), co-infected with wt and D125A (MOI 1 and 10, respectively; lane 2), or inf
4 is from mock-infected cells. Cell lysates were analyzed by SDS-PAGE and radioﬂuorograph
standard deviation).in contrast to what was observed at 8 hpi (Fig. 4A–C). These data
indicated that the reduced viral protein synthesis observed is not due
solely to expression of the D125A mutant, but occurs in the context
of VSV infection, perhaps requiring other viral proteins or products.
Viral mRNA is not the limiting factor in the rVSV-D125A protein
synthesis defect
To determine if the reduced levels of viral protein synthesis seen
in rVSV-D125A infected cells were due to a reduction in viral mRNA,
we performed quantitative RT-PCR (qRT-PCR) on RNA isolated from
infected BHK cells at varying times post-infection. Cells were infected
with rVSV-wt or rVSV-D125A at anMOI of 10, RNAwas isolated at 1, 5
or 7 hpi, and the amounts of VSV genomic RNA and P mRNA were
determined. We found that the ratio of P mRNA to genomic RNA was
~8-fold higher at 5 hpi and 20-fold higher at 7 hpi in rVSV-D125A
infected cells when compared to rVSV-wt infected cells (Fig. 5A).
Importantly, the amounts of genomic RNA present for the two viruses
were not signiﬁcantly different (Fig. 5B). These results indicate that
decreased mRNA synthesis was not responsible for the reduced viral
protein synthesis seen with the rVSV-D125A mutant. In fact, there
was signiﬁcantly more viral mRNA per genome in the mutant infected
cells than in rVSV-wt infected cells.
Co-infection with rVSV-wt partially rescues the protein
translation defect
To determine if rVSV-wt infection could rescue the protein
synthesis defect of the rVSV-D125A mutant, we co-infected BHK
cells with rVSV-wt and rVSV-D125A using the synchronized fusion
method as described for Fig. 3. Cells were either singly infected with
rVSV-wt (MOI 1), doubly infected with rVSV-wt (MOI 1) and rVSV-
D125A (MOI 10), or singly infected with rVSV-D125A (MOI 10). At
9 hpi cells were pulse-labeled with 35S-Met and analyzed by SDS-
PAGE, radioﬂuorography, and phosphorimaging (Fig. 6). We found
that co-infection could partially rescue the protein synthesis defect
(Fig. 6A, compare lanes 2 and 3), increasing the amount of viral
proteins made 3-fold from approximately 20–60% of the amount
made in rVSV-wt infected cells (Fig. 6B). These data indicate that
D125A does not have a dominant-negative effect on translation.
rVSV-D125A infection does not reduce cap-independent
protein synthesis
To determine if cap-independent protein synthesis was affected
in rVSV-D125A infected cells, we transfected BSR cells constitutively
expressing T7 polymerase with a plasmid that has a T7 promoter
driving expression of the luciferase gene with an encephalomyocar-
ditis virus (EMCV) IRES leader. At 18 h p.t., cells were mock infected,t. (A) Viral protein synthesis in BHK-21 cells was examined in cells infected with rVSV-
ected with rVSV-D125A (MOI 10; lane 3) by 35S-methionine pulse labeling at 9 hpi. Lane
y. (B) Quantitation of protein synthesis by phosphorimager analysis (n=3; error bars,
Fig. 7. EMCV/IRES-driven expression of luciferase is not affected in rVSV-D125A
infected BSR cells. BSR cells constitutively expressing T7 RNA polymerase were
transfected with a plasmid that expresses IRES-luciferase from a T7 promoter. Eighteen
hours post-transfection the cells were mock treated/infected, treated with cyclohex-
imide, or infected with rVSV-wt (Wt) or rVSV-D125A (D125A). Luciferase activity was
measured 6 h after cycloheximide treatment, or 3, 6, or 12 hpi (n=3; error bars,
standard deviation).
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at an MOI of 10, and cell lysates were analyzed for luciferase activity
at increasing times post-infection. The results (Fig. 7) showed a slight
reduction in luciferase activity in the rVSV-D125A infected cells
compared to wt-infected cells, but this difference was not statistically
signiﬁcant, indicating that the mechanism responsible for the re-
duced protein synthesis seen at increasing times post-infection in
rVSV-D125A infected cells primarily affected synthesis of proteins
produced by a cap-dependent mechanism.Discussion
The initial crystallization of the VSV-Ind M protein was made
possible by proteolytic cleavage of an exposed loop (amino acids 121–
128) that prevented M self-association (Barge et al., 1996; Gaudier
et al., 2001, 2002; Gaudin et al., 1995, 1997). The self-association of
uncleaved M protein can be prevented by high salt (Gaudin et al.,
1995), which also causes the release of M from skeletons and sub-
sequent RNP decondensation (Newcomb et al., 1982). These obser-
vations suggested that the exposed loop may be involved in virus
assembly, speciﬁcally RNP condensation into skeletons. Previously,
others reported that mutations of amino acids 121–124 within the
loop resulted in a minor assembly defect, but the major effect of the
mutations was an unexpected reduction in viral protein synthesis
(Connor et al., 2006). Here, we report that mutations in the conserved
LXD motif (amino acids 123–125) within the loop region have two
major effects on VSV biology, namely, an effect on virus assembly and
an effect on viral protein synthesis.
Transient expression of a series of M protein loop mutants
revealed no discernable differences in the cellular distribution or
budding activity for any of the mutants when compared to Mwt;
however, we could only recover rVSVs encoding three of the eight
mutants despite multiple attempts (n=6 per virus). These data
indicated that the size of the loop and speciﬁc residues within the loop
were essential for M protein function required for virus recovery. For
the rVSV mutants that were recovered, the viruses displayed reduced
growth kinetics (Figs. 2A and 3C) that correlated with reduced virus
budding (Fig. 3A and B) compared to rVSV-wt. These data suggested
the mutations in the loop of M affected the efﬁciency of VSV assembly
and we propose that this is due to inefﬁcient condensation of RNPs
into skeletons. Additional observations supporting this hypothesis
include the high viral mRNA to genome ratio found in rVSV-D125A
infected cells (Fig. 5) and the increased level of M protein exchange
seen with rVSV-D125A skeletons (Fig. 3D). The high viral mRNA to
genome ratio suggested that the genomes in the rVSV-D125A cellswere less condensed than the rVSV-wt genomes since M condensa-
tion of the RNP is thought to inhibit transcription (Carroll and
Wagner, 1979; Pal et al., 1985). This is supported by the exchange of
M protein with rVSV-D125A skeletons, but not with rVSV-wt skeletons,
which we propose reﬂects the less condensed nature of D125A
skeletons. These data, together with the crystal structure of VSV-NJ
M oligomers which shows M–M interactions involving amino acids
120–128 (Graham et al., 2008), and the cryo-EMmodel of VSV virions
where amino acids 120–128 are in contact 4 of the M-hub which is
important in setting the vertical spacing of the M protein helix (Ge
et al., 2010), suggest that the LXD motif is important for efﬁcient
condensation of VSV RNPs by M into skeletons.
In addition to the effects on virus assembly, some of the mutations
in the loop region also inhibited viral protein expression, similar to
that reported by others for a different set of loop mutations (Connor
et al., 2006). We quantiﬁed the amount of VSV mRNA synthesized in
rVSV-wt and D125A infected cells and found the reduced level of
VSV protein synthesis was not due to reduced viral mRNA production.
We also found this was not due to differences in PKR-mediated
phosphorylation of eIF2α, nor to enhanced RNAse L activation, andwe
detected no difference in cleavage of pro-caspase 3 to caspase 3, or
conversion of LC3 to LC3B in rVSV-D125A versus rVSV-wt infected
cells (data not shown). These data suggested the reduced protein
synthesis was not due to an enhanced host response to rVSV-D125A
infection, but a more thorough examination of each of these processes
individually needs to be conducted before they can be completely
ruled out as having no effect on VSV protein synthesis in rVSV-D125A
infected cells.
Recently, a new model was proposed for control of host and viral
protein synthesis in VSV-infected cells (Connor and Lyles, 2002). This
model proposes that alterations of the eIF4F cap-binding complex
result in inhibition of host protein synthesis and the pre-existing
host mRNAs are then shuttled to inactive mRNPs which in turn
allows for newly made viral mRNA to be translated. A follow-up
study showed that this effect was not speciﬁc to newly made VSV
mRNAs but also occurred with a reporter expressed during VSV
infection (Whitlow et al., 2008). These observations suggest that the
time when mRNAs enter the translation machinery after VSV
infection is critical for preferential translation and is not the result
of cis-acting structural elements in the 5′ untranslated region (UTR)
of VSV mRNA, as has also been suggested (Whitlow et al., 2006).
Interestingly, the major effects of alterations to the eIF4F cap-binding
complex on host protein translation during VSV infection occur
between 4 and 8 hpi (Black et al., 1994; Connor et al., 2006; Whitlow
et al., 2008), which was the time post-infection that we observed a
reduction in both viral and host protein synthesis in the mutant
infected cells (Fig. 4A and C). Therefore, the dramatic reduction in
VSV protein synthesis seen in this study may reﬂect the inability of
the D125A mutant to positively regulate viral protein synthesis
beginning ~4 hpi. Whether this positive translation regulation by
Mwt at later times post-infection is due to its ability to support the
initiation of translation using altered eIF4F cap-binding complexes or
is due to some other mechanism, it is clear that VSV M protein
contributes to regulation of protein translation after ~4 hpi and that
for VSV-Ind M, amino acids 121–125 are important for this effect,
with the D125 residue being critical.
Eukaryotic protein translation initiation is a complex process that
requires many co-factors, but cap-independent translation of mRNA
from picornaviruses, such as encephalomyocarditis virus (EMCV), re-
quires a smaller number of initiation factors when compared to those
required for cap-dependent translation initiation (Pestova et al.,
2001). EMCV mRNA contains a 5′ UTR that has an internal ribosome
entry site (IRES) (Hellen and Wimmer, 1995; Jang et al., 1990) and
initiation of translation from the EMCV IRES in vitro only requires ATP,
eIF2, eIF3, eIF4A or eIF4F, and the central portion of eIF4G (Pestova
et al., 2001). Although it is still possible that the reduction in viral
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to an untested host response induced by inefﬁcient virus assembly,
our results suggest that the effect was more likely due to the inability
of the M loop mutant proteins to positively regulate VSV translation
after 4 hpi. Indeed, we found that EMCV IRES-driven luciferase
expression was not signiﬁcantly affected by rVSV-D125A infection. In
fact, there was a slight increase in luciferase expression at 6 hpi in
rVSV-D125A infected cells when compared to mock-infected cells
(Fig. 7) where newly made mRNA should be preferentially translated
(Whitlow et al., 2008). These data suggest that a cap-dependent
translation initiation factor is involved in the protein synthesis effect
observed during rVSV-M loop mutant infections. One candidate
factor is eIF4E since it is the only major initiation factor that is not
required for EMCV IRES protein translation initiation but it is
required for cap-dependent β-globin mRNA translation (Pestova
et al., 2001). Previously it was proposed that dephosphorylation of the
eIF4E binding protein 4E-BP1 contributes to the reduction in host
protein translation during VSV infection (Connor and Lyles, 2002).
The data presented here, together with that published by others
(Black et al., 1994; Connor and Lyles, 2002, 2005; Connor et al., 2006;
Whitlow et al., 2006, 2008), suggests that M protein may support VSV
translation at later times post-infection by compensating for the
alteration of the eIF4F cap-binding complex The hypothesis that M
may be able to substitute for or enhance eIF4E activity is intriguing
since the two proteins are similar in size, both have an unstructured
N-terminus, and have similar crystal structures (Brown et al., 2007;
Gaudier et al., 2002). Whether the assembly and translational pheno-
types of the LXD mutants described here can be separated genetically
will require additional investigation. Alternatively, the LXD motif
could be the ﬁrst dual function motif of the M protein described
to date.
Materials and methods
Plasmid design and construction
Construction of the cDNAs containing the loop mutations in Mwas
accomplished using an overlap PCR strategy with mutagenic primers
and pBluescript (pBS) M-Lumio (Mire et al., 2009) as the template.
Complementary mutagenic primers (sequences available upon re-
quest) were used with either a 5′ forward primer (CEM 1) or a 3′
reverse primer (T3) to generate the mutants: Δ Loop, 2X Loop, A Loop,
D Loop, D125A, D125E, L123A, and L123S. A second round of PCR
ampliﬁcation, with the overlapping 5′ and 3′ fragments used as the
templates, together with the two outside primers (CEM 1 and T3)
were used to create the desired mutations in the M-Lumio gene. The
PCR products were gel puriﬁed, digested with AscI and EagI, gel puri-
ﬁed again, and ligated into pBS-SK-ΦT (Stillman et al., 1995) cut with
the same enzymes.
Generation of full-length VSV cDNAs encoding M loop mutants
Creation of the full-length VSV genomes with M loop mutants was
accomplished by separately cloning each sequence into pVSV-ΔM-PL,
which encodes a VSV anti-genome that has a multiple cloning site
in the place of the M protein coding sequence (Jayakar et al., 2000).
For each construct the plasmids were digested with AscI and EagI, and
the ΔM vector and M loop mutant fragments were gel puriﬁed and
ligated by twoway ligation to create pVSV-“LoopMutant” (e.g., pVSV-
D125A, etc.).
Recovery and characterization of recombinant VSV (rVSV)
Recombinant viruses were recovered using reverse genetics
(Lawson et al., 1995) with somemodiﬁcations as described previously
(Jayakar et al., 2000). Single-step growth curves were performed byadsorbing virus to baby hamster kidney (BHK-21) cells in 35 mm
plates at a multiplicity of infection (MOI) of 10 for 1 h while con-
tinually rocking. The inoculum was removed, the cells were washed
4x with serum-free Dulbecco's minimal Eagle's medium (DMEM) to
remove unbound virus, DMEM containing 5% fetal bovine serum (FBS)
was added, and the cells were placed at 37 °C. Every 2 h post-infection
(hpi) a 5% aliquot of media was collected, replaced with the same
volume of fresh media, and then virus titers were determined in
duplicate by plaque assay on BHK-21 cells. Growth curves were
performed in triplicate for each virus. Relative infectivity was assessed
by Coomassie-blue staining after SDS-PAGE analysis of 1 x 107 PFU
of rVSV.
TEM of rVSV
To conﬁrm the morphology of rVSV, puriﬁed virus was resus-
pended in 10% sucrose 10 mM Tris–HCl [pH 8.0], 150 mM NaCl
solution and placed on ice. To decrease the sucrose concentration, the
virus preparations were then diluted 1:10 in dH2O and prepared for
transmission electron microscopy (TEM) after adsorbing virus to a
carbon-coated grid by placing the grid on a drop of virus suspension,
and negative staining with 2% phosphotungstic acid (PTA, pH 5.9).
Transient expression of M loop mutants
BHK-21 cells at ~90% conﬂuence on glass cover slips were
infected with a modiﬁed vaccinia virus (vTF7-3) encoding T7 RNA
polymerase (Fuerst et al., 1987) at MOI 5 for 1 h at 31 °C in SF-
DMEM. The inoculum was removed and the cells were transfected
with 5 μg of pBS-MΦT (wild-type; Indiana) or pBS-(Loop Mutant)
using 20 μl TransfectACE in SF-DMEM (Rose et al., 1991). Five hours
post-transfection (p.t.) the transfection mix was removed and re-
placed with 5% FBS DMEM containing antibiotics (100 U/ml strep-
tomycin and penicillin), and 18 h p.t. the cells were ﬁxed and
processed for immunoﬂuorescence or were used in a budding assay
as described below.
Immunoﬂuorescence (IF) staining and confocal microscopy
Cells either transiently expressing M proteins from plasmids or
infected with rVSV were washed twice with phosphate-buffered
saline (PBS) and then ﬁxed for 15 min with 3% paraformaldehyde
(PFA) in PBS at room temperature (r.t.). The ﬁx solution was then
removed and the cells washed twice with PBS containing 10 mM
glycine and 0.05% sodium azide (PBS–glycine), and then permeabi-
lized with 1% Triton X-100 in PBS–glycine at r.t. for 1 min. After
permeabilization, the cells were washed twice with PBS–glycine and
then stained for M protein using an anti-M monoclonal antibody
(mAb 23H12) conjugated to Alexa-488. The distribution of the M
proteins was examined using laser scanning confocal microscopy
(Zeiss LSM 510). Optical slices of 1 μm were captured using 488 nm
laser excitation.
Budding assays
Cells transiently expressing the indicated M protein were washed
twice with methionine-free SF-DMEM and then incubated in this
media for 15 min to deplete the intracellular methionine pools at 5 h
p.t. After depletion, a medium composed of 1 part 5% FBS DMEM to
9 parts methionine-free media and supplemented with 50 μCi of
35S-Methionine (Met) Express Protein Labeling Mix (Perkin-Elmer)
per ml was added and 18 h later media and cells were collected
separately and processed for immunoprecipitation (IP). The media
were centrifuged at 170×g for 10 min to remove dislodged cells and
the supernatant was placed on ice after addition of 200 U of aprotinin
(U.S. Biochemicals). The supernatant was made to 50 mM Tris–HCl,
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radiolabeled M proteins were immunoprecipitated with M mAb
(23H12) overnight at 40C. Cell extracts were prepared by washing the
cells twice with PBS and then lysing with 800 μl of Detergent Solu-
tion (10 mM Tris–HCl [pH 7.4], 66 mM EDTA, 0.4% sodium deox-
ycholate, 1% Triton X-100, 0.05% NaN3) containing 200 U/ml of
aprotinin for 5 min at r.t. on a rocker. The cell extract was collected,
nuclei and insoluble material were removed by centrifugation at
10,000×g for 5 min and a 200 μl aliquot of the cell extract was made
to 0.3% SDS and immunoprecipitated with M mAb (23H12) overnight
at 4 °C. One-quarter of the radiolabeled M proteins in the cell extracts
were compared to the amount released into the supernatant by SDS
polyacrylamide gel electrophoresis (PAGE) on a 9% polyacrylamide
gel and visualized by radioﬂuorography.
35S-methionine pulse labeling of rVSV-infected cells
BHK-21 and HeLa cells were infected with rVSV at an MOI of 10.
At increasing times post-infection the cells were starved of methio-
nine for 10 min and then a 35S-Met labeling mix at 50 μCi/ml was
added to the cells for 10 min. Cell extracts were prepared by washing
the cells twice with PBS and then lysing with 400 μl of Detergent
Solution containing 200 U/ml of aprotinin for 5 min at r.t. on a rocker.
The nuclei and insoluble material were removed by centrifugation at
10,000×g for 5 min and 5% of the cell extract was analyzed by
SDS-PAGE radioﬂuorography and quantiﬁed by phosphorimaging
using a STORM (Molecular Dynamics) scanner.
rVSV budding assay
BHK-21 cells were infected with rVSV at an MOI of 10. At 3 hpi,
cells were starved of methionine for 10 min and then an 35S-Met
labeling mix at 50 μCi/ml was added to the cells for 1 h. The
supernatant was then collected and virus was isolated from the
supernatant by ultracentrifugation (35 min, 45 K rpm, Sorvall,
AH-650) over a 20% sucrose–TN (10 mM Tris–HCl [pH 8.0], 150 mM
NaCl) cushion. Also, cell extracts were prepared by washing the cells
twice with PBS and then lysing with 400 μl of Detergent Solution
containing 200 U/ml of aprotinin for 5 min at r.t. on a rocker. The
nuclei and insoluble material were removed by centrifugation at
10,000×g for 5 min. The whole viral pellet and 5% of the cell extract
were analyzed by SDS-PAGE radioﬂuorography and quantiﬁed by
phosphorimaging using a STORM scanner.
Synchronized fusion co-infection assay
To prevent the acidiﬁcation of endosomes and synchronize fusion
of virions with endosomal membranes we used the lysosomotropic
reagent NH4Cl as described previously (Mire et al., 2010; Rigaut et al.,
1991) with some modiﬁcations. BHK-21 cells were washed twice
with PBS and then washed twice with PBS containing 100 mM NH4Cl.
rVSV (MOI 1), rVSV-D125A (MOI 10), or rVSV-wt (MOI 1) and rVSV-
D125A (MOI 10) were adsorbed in SF-DMEM containing 100 mM
NH4Cl for 90 min. After adsorption the cells were washed with PBS
four times to remove the NH4Cl and protein synthesis or virus
budding was examined by 35S-Met pulse labeling as described above.
RNP exchange assay
35S-Met labeled Mwt or M D125A mutant protein was made from
plasmids in a TNT T7 in vitro transcription and translation reaction
(# L4610, Promega) in the presence of 35S-methionine labeling mix
(# AG1594, GE Healthcare). Five microliters of either translation
reaction was added to 10, 50, or 100 μg of solubilized rVSV-wt or
rVSV-D125A in TN (Tris–HCl (pH 8.0), 150 mM NaCl) buffer. The
mixtures were placed on ice for 10 min and then the skeletons andsupernatants were separated by ultracentrifugation (35 min,
45 K rpm, Sorvall, AH-650) over a 20% sucrose–TN cushion. Pellets
and TCA precipitated supernatants were then analyzed by SDS-PAGE
radioﬂuorography.
qRT-PCR analysis
To rule out viral mRNA as the limiting factor in the reduction in
protein synthesis during infection, real-time RT-PCR was performed
on BHK-21 cells infected with rVSV at an MOI of 10. At increasing
times post-infection cell lysates were collected in Trizol reagent
(# 15596–018, Invitrogen) and total RNA was extracted. Reverse
transcription was performed using a primer (MR Nest) on a known
amount of genomes (from 101 to 1013) to produce a standardized
genomic curve for RT-PCR. Reverse transcription was also performed
on total RNA extracted from cells using a poly dT primer formRNA and
a primer (MR Nest) that annealed to the intergenic region between
M and G for genomes. RT-PCR was then performed and RNA was
quantiﬁed using SYBR Green for genomes (primers CEM 2 and MR
Nest) and P mRNA (P82F and P-210-REV) in a DNA Engine Opticon
system and software (MJ Research/BioRad).
Luciferase assay
BSR-T7 cells (BHKs constitutively expressing T7 RNA polymerase,
(Buchholz et al., 1999)) were transfected with 5 μg of a plasmid that
expressed luciferase with an internal ribosome entry site (pEMCV/
IRES-Luc) and 18 h p.t. the cells were mock infected/treated, treated
with cycloheximide (10 μg/ml), or infected with rVSV-wt or rVSV-
D125A at an MOI of 10. Mock and cycloheximide treated cell lysates
were assessed for luciferase activity at 6 h post-treatment and
luciferase activity was measured at increasing times post-infection
in infected cells as described above.
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